Nature Medicine, Published online: 02 June 2026; doi:10.1038/s41591-026-04442-2 A randomized, single-blind, parallel-group, phase 1b clinical trial compared fecal microbiota transplant or a 15-strain live biotherapeutic product (MTC01) derived from the same donor and found similar efficacy and engraftment between treatments.